PTC Therapeutics Inc. buy Morgan Stanley
Start price
20.08.25
/
50%
€41.60
Target price
20.08.26
€61.05
Performance (%)
44.28%
Price
09.04.26
€60.26
Summary
This prediction is currently active. With a performance of 44.28% the BUY prediction by Morgan_Stanley is a big success. This prediction currently runs until 20.08.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | 2.701% | 2.701% |
| iShares Core DAX® | 3.075% | 0.488% |
| iShares Nasdaq 100 | 2.876% | 0.081% |
| iShares Nikkei 225® | 5.981% | 3.033% |
| iShares S&P 500 | 2.231% | 0.046% |
Comments by Morgan_Stanley for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics (NASDAQ:PTCT) had its price target lowered by analysts at Morgan Stanley from $76.00 to $71.00. They now have an "overweight" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Morgan_Stanley for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€48.60
07.03.25
07.03.25
€64.54
07.03.26
07.03.26
9.05%
08.03.26
08.03.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€43.80
13.12.24
13.12.24
€63.72
13.12.25
13.12.25
43.84%
14.12.25
14.12.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.80
19.12.23
19.12.23
€25.54
19.12.24
19.12.24
73.39%
20.12.24
20.12.24